重组Klotho蛋白通过减轻失血性休克后无菌性炎症的有害效应保护组织
研究在成年雄性Wistar大鼠可控失血性休克并复苏模型中,设假手术组、假手术+重组Klotho蛋白组、失血性休克组和失血性休克+重组Klotho蛋白组,通过组织病理学、TUNEL、活性氧染色、ELISA、实时聚合酶链反应、细胞因子阵列、M1/M2巨噬细胞标记免疫荧光及高迁移率族蛋白B1检测评估炎症、凋亡和巨噬细胞极化。结果显示重组Klotho蛋白给药明显减轻肺和肾组织学损伤、降低乳酸水平、抑制凋亡和活性氧蓄积。重组Klotho蛋白还抑制高迁移率族蛋白B1的细胞外释放、降低促炎细胞因子表达。重组Klotho蛋白减少巨噬细胞浸润和M1极化、提高M2/M1比值,提示炎症消退增强。作者结论认为重组Klotho蛋白通过减少活性氧、凋亡和炎症以及调节巨噬细胞极化减轻失血性休克后组织损伤,可能作为改善失血性休克结局的有前景的辅助治疗策略。
要点
- 成年雄性Wistar大鼠可控失血性休克并复苏模型中,重组Klotho蛋白给药明显减轻肺和肾组织学损伤、降低乳酸水平。
- 重组Klotho蛋白抑制凋亡和活性氧蓄积,并抑制高迁移率族蛋白B1细胞外释放、降低促炎细胞因子表达。
- 重组Klotho蛋白减少巨噬细胞浸润和M1极化、提高M2/M1比值,提示炎症消退增强。
- 作者认为重组Klotho蛋白可能作为改善失血性休克结局的有前景的辅助治疗策略。
适用人群与场景
- 成年雄性Wistar大鼠,接受可控失血性休克并复苏。
研究设计与关键结果
- 研究类型为动物实验,成年雄性Wistar大鼠分为四组:假手术组、假手术+重组Klotho蛋白组、失血性休克组、失血性休克+重组Klotho蛋白组。
- 重组Klotho蛋白给药明显减轻肺和肾组织学损伤、降低乳酸水平、抑制凋亡和活性氧蓄积。
- 重组Klotho蛋白抑制高迁移率族蛋白B1的细胞外释放并降低促炎细胞因子表达。
- 重组Klotho蛋白减少巨噬细胞浸润和M1极化、提高M2/M1比值,提示炎症消退增强。
证据类型、等级与局限
- 证据类型:动物实验(大鼠失血性休克模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为重组Klotho蛋白可能作为改善失血性休克结局的有前景的辅助治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhagic shock (HS) is a life-threatening condition characterized by systemic hypoperfusion, which induces inflammatory responses, oxidative stress, and apoptosis, often leading to multiple organ failure. Klotho, an antiaging protein with anti-inflammatory, antiapoptotic, and antioxidative properties, has demonstrated therapeutic potential in chronic diseases. However, its efficacy in acute conditions, such as HS, remains unexplored.
OBJECTIVE: This study investigated the protective effects of recombinant klotho protein (rKL) on the lungs and kidneys after HS and elucidated the underlying mechanisms.
METHODS: Adult male Wistar rats were subjected to controlled HS, followed by resuscitation. The animals were divided into four groups: sham, sham + rKL, HS, and HS + rKL. Histopathological analysis, terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick end labeling assay, reactive oxygen species (ROS) staining, enzyme-linked immunosorbent assay, real-time polymerase chain reaction, cytokine array, immunofluorescence staining for M1 and M2 macrophage markers, and high mobility group box-1 protein were performed to evaluate inflammation, apoptosis, and macrophage polarization.
RESULTS: rKL administration markedly attenuated histological tissue damage in the lungs and kidneys, reduced lactate levels, and suppressed apoptosis and ROS accumulation. Furthermore, rKL inhibited the extracellular release of high mobility group box-1 protein and decreased the expression of proinflammatory cytokines. rKL also reduced macrophage infiltration and M1 polarization while increasing the M2/M1 ratio, indicating enhanced resolution of inflammation.
CONCLUSIONS: rKL attenuates tissue injury after HS by reducing ROS, apoptosis, and inflammation, as well as modulating macrophage polarization. These findings suggest that rKL may serve as a promising adjunctive therapeutic strategy for improving HS outcomes.
参考来源
- Park Y, Woo JS, Park YS, et al. Recombinant Klotho Protein Protects Tissues by Mitigating the Detrimental Effects of Sterile Inflammation After Hemorrhagic Shock. Shock. 2025. PMID: 41490215. doi:10.1097/SHK.0000000000002755
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。